Medical devices, healthcare technology and the business of care
510(k) clearance · K254058

DistaSense(TM) (v1)

Life Detection Technologies · Decision date Sep 25, 2026

MEDTECHLEDGER EXPLANATIONK254058

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for DistaSense(TM) (v1), submitted by Life Detection Technologies of Sunnyvale, California, under 510(k) number K254058. The decision date is 2026-09-25 and the application was received 12/17/2025. The device falls under regulation 870.2300 with classification product code DRT, a subsequent product code of BZQ, and the cardiovascular medical specialty and review panel. A SESE decision is a 510(k) clearance, not a PMA approval.

The FDA summary describes DistaSense as a contactless device intended to measure heart rate and respiration rate in healthy adult patients at rest, for use by healthcare professionals, caregivers and patients, with no patient contact. The record lists a traditional summary type, no third-party review, no combination product status and no authorized predetermined change control plan. The source does not provide performance testing results, comparison predicates or the full indications wording, so the basis for the equivalence finding remains unknown from this material.

Readers should not infer clinical accuracy, comparative performance or current labeling from the clearance alone; the summary excerpts are partial and the underlying decision rationale is not included.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 25, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254058
Regulatory pathway
510(k) premarket notification
Product code
DRT
Decision code
SESE
Decision date
Sep 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Monitor, Cardiac (Incl. Cardiotachometer & Rate Alarm).

Product code
DRT
FDA device class
2

FDA decision timeline

  1. K254058 received

    Application receipt date recorded by FDA.

  2. K254058 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DRT

Product / regulatory recordCompanyPathwayDecision dateSource
Circadia Health, Inc.510(k) clearanceOct 15, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Life Detection Technologies

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Sunnyvale, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records